Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2021-07-22
Original market date: See footnote 1
Product name:
NX 12 HOUR
Description:
TABLETS AND CAPLETS
DIN:
02378663
Product Monograph/Veterinary Labelling:
Date:
2012-01-17
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PERRIGO INTERNATIONAL
515 Eastern Ave
Allegan
Michigan
United States
49010-1327
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
28:08.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
M01AE02 NAPROXEN
Active ingredient group (AIG) number:See footnote5
0113934003
| Active ingredient(s) | Strength |
|---|---|
| NAPROXEN SODIUM | 220 MG |